Special Report
Bone Marrow Transplantation (2006) 37, 249–261. doi:10.1038/sj.bmt.1705243
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT)
This article is being published concurrently in Biology of Blood and Marrow Transplantation, 12 000–000. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article.
J D Rizzo1, J R Wingard2, A Tichelli3, S J Lee4, M T Van Lint5, L J Burns6, S M Davies7, J L M Ferrara8 and G Socié9
- 1Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, USA
- 2University of Florida College of Medicine, Gainesville, FL, USA
- 3Kantonsspital, Basel, Switzerland
- 4Dana-Farber Cancer Institute, Boston, MA, USA
- 5San Martino Hospital, Genova, Italy
- 6University of Minnesota, Minneapolis, MN, USA
- 7Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA
- 8University of Michigan, Ann Arbor, MI, USA
- 9Hôpital St Louis, Paris, France
Correspondence: Professor Dr G Socié, Department of Hematology, Bone Marrow Transplant, Hôpital St. Louis, 1, Avenue Claude Vellefaux, Paris F-75475, Cedex 10, France. E-mail: gerard.socie@paris7.jussieu.fr
Received 15 July 2005; Revised 23 September 2005; Accepted 27 September 2005.
Abstract
More than 40 000 hematopoietic cell transplants (HCTs) are performed worldwide each year. With improvements in transplant technology, larger numbers of transplant recipients survive free of the disease for which they were transplanted. However, there are late complications that can cause substantial morbidity. Many survivors are no longer under the care of transplant centers and many community health-care providers may be unfamiliar with health matters relevant to HCT. The Center for International Blood and Marrow Transplant Research (CIBMTR), European Group for Blood and Marrow Transplantation (EBMT), and American Society for Blood and Marrow Transplantation (ASBMT) have developed these recommendations to offer care providers suggested screening and prevention practices for autologous and allogeneic HCT survivors.
Keywords:
late effects, HCT (hematopoietic cell transplantation), screening, prevention